Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 4/20 | 0.52 |
| ▸ | BID | P55957 | 3/20 | 0.52 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.52 |
| ▸ | KAT8 | Q9H7Z6 | 3/20 | 0.52 |
| ▸ | BCL2L1 | Q07817 | 2/20 | 0.52 |
| ▸ | BAK1 | Q16611 | 2/20 | 0.52 |
| ▸ | PPARG | P37231 | 2/20 | 0.52 |
| ▸ | SAE1 | Q9UBE0 | 2/20 | 0.52 |
| ▸ | EP300 | Q09472 | 2/20 | 0.52 |
| ▸ | KAT5 | Q92993 | 2/20 | 0.52 |
| ▸ | KAT2A | Q92830 | 1/20 | 0.52 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.52 |
| ▸ | PLK1 | P53350 | 4/20 | 0.46 |
| ▸ | F7 | P08709 | 3/20 | 0.46 |
| ▸ | F3 | P13726 | 3/20 | 0.46 |
| ▸ | MMP2 | P08253 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | ECE1 | P42892 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phthalic Acid SCHEMBL7126032 | 1.00 | PPARA (0.52) | PPARABIDMCL1KAT8BCL2L1 | |
| Phthalic Acid SCHEMBL27562902 | 1.00 | PPARA (0.52) | PPARABIDMCL1KAT8BCL2L1 | |
| Phthalic Acid SCHEMBL30774355 | 0.99 | PPARA (0.51) | PPARABIDMCL1KAT8BCL2L1 | |
| SCHEMBL10831711 | 0.94 | PPARA (0.54) | PPARABIDMCL1KAT8BCL2L1 | |
| SCHEMBL10831730 | 0.94 | PPARA (0.54) | PPARABIDMCL1KAT8BCL2L1 | |
| SCHEMBL826803 | 0.94 | PPARA (0.54) | PPARABIDMCL1KAT8BCL2L1 | |
| SCHEMBL8733022 | 0.94 | PPARA (0.54) | PPARABIDMCL1KAT8BCL2L1 | |
| SCHEMBL183977 | 0.94 | PPARA (0.54) | PPARABIDMCL1KAT8BCL2L1 | |
| SCHEMBL10833218 | 0.94 | PPARA (0.54) | PPARABIDMCL1KAT8BCL2L1 | |
| SCHEMBL724309 | 0.94 | PPARA (0.54) | PPARABIDMCL1KAT8BCL2L1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12569403-B2 | Capsule with reduced powder leakage | CAPSUGEL BELGIUM NV (BE) | 2026-03-10 | — | — | US | disclosed |
| EP-4251126-B1 | DOUBLE LAYERED DELAYED-RELEASE HARD CAPSULES | CAPSUGEL BELGIUM NV (BE) | 2026-02-18 | — | — | EP | disclosed |
| EP-4674411-A2 | DOUBLE LAYERED DELAYED-RELEASE HARD CAPSULES | Capsugel Belgium NV (BE) | 2026-01-07 | — | — | EP | disclosed |
| CN-119907688-A | Shading hard capsule containing magnesium oxide | 比利时胶囊公司 | 2025-04-29 | — | — | CN | disclosed |
| EP-4069178-B1 | CAPSULE WITH REDUCED POWDER LEAKAGE | CAPSUGEL BELGIUM NV (BE) | 2025-03-12 | — | — | EP | disclosed |
| EP-4467132-A2 | DOUBLE LAYERED DELAYED-RELEASE HARD CAPSULES | Capsugel Belgium NV (BE) | 2024-11-27 | — | — | EP | disclosed |
| EP-4464313-A2 | DOUBLE LAYERED DELAYED-RELEASE HARD CAPSULES | Capsugel Belgium NV (BE) | 2024-11-20 | — | — | EP | disclosed |
| US-20240317645-A1 | Binder Composition and Method Thereof | DESAI BINISH (US) | 2024-09-26 | — | — | US | disclosed |
| CN-117306064-B | Preparation process of disposable underpants with high elasticity and product thereof | 广东启悦未来科技股份有限公司 | 2024-05-10 | — | — | CN | disclosed |
| CN-117306064-A | Preparation process of disposable underpants with high elasticity and product thereof | 广东启悦未来科技股份有限公司 | 2023-12-29 | — | — | CN | disclosed |
| US-20230017517-A1 | CAPSULE WITH REDUCED POWDER LEAKAGE | CAPSUGEL BELGIUM NV (BE) | 2023-01-19 | — | — | US | disclosed |
| EP-3983477-B1 | FILM, CAPSULE AND FILM-FORMING COMPOSITION COMPRISING WATER-SOLUBLE SALT AS OPACIFYING AGENT | CAPSUGEL BELGIUM NV (BE) | 2022-11-02 | — | — | EP | disclosed |
| EP-4069178-A1 | CAPSULE WITH REDUCED POWDER LEAKAGE | Capsugel Belgium NV (BE) | 2022-10-12 | — | — | EP | disclosed |
| US-20220218619-A1 | FILM, CAPSULE AND FILM-FORMING COMPOSITION COMPRISING WATER-SOLUBLE SALT AS OPACIFYING AGENT | CAPSUGEL BELGIUM NV (BE) | 2022-07-14 | — | — | US | disclosed |
| WO-2022112422-A1 | DOUBLE LAYERED DELAYED-RELEASE HARD CAPSULES | Capsugel France SAS (FR) | 2022-06-02 | — | — | WO | disclosed |
| EP-3983477-A1 | FILM, CAPSULE AND FILM-FORMING COMPOSITION COMPRISING WATER-SOLUBLE SALT AS OPACIFYING AGENT | Capsugel Belgium NV (BE) | 2022-04-20 | — | — | EP | disclosed |
| CN-101274997-B | Biocidal compositions | TROY CORP | 2013-05-08 | — | — | CN | disclosed |
| CN-101274997-A | Biocidal compositions | TROY TECHNOLOGY CORP INC (US) | 2008-10-01 | — | — | CN | disclosed |
| EP-0735005-A2 | Process for treating recalcitrant compounds | ZENON ENVIRONMENTAL INC. (CA) | 1996-10-02 | — | — | EP | disclosed |
| US-5558774-A | BIOOXIDATION, THERMOPHILIC MICROORGANISMS, WASTES FROM FOOD PROCESSING, METAL WORKING, PLASTICIZERS | ZENON ENVIRONMENTAL INC. (CA) | 1996-09-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12569403-B2 | Capsule with reduced powder leakage | EXOSC4, EXOSC10, CAP1 | PPARA 3663/4885BID 4473/4885MCL1 4228/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.